Jasper Therapeutics, Inc.

Biotechnology • Healthcare • Redwood City, CA, United States • JSPRW (NCM)

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.

650 549 1400 2200 Bridge Pkwy, Redwood City, CA 94065, United States

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Yahoo Finance • Nov 10

Can Jasper Therapeutics’ Progress Propel Its Stock? - timothysykes.com

timothysykes.com • Dec 2

Jasper Therapeutics’ Briquilimab: Stepping Up? - StocksToTrade

StocksToTrade • Dec 2

Jasper Therapeutics Reports Positive Results For Briquilimab In Allergic Asthma Phase 1b Study - Nasdaq

Nasdaq • Dec 2

Jasper Therapeutics stock falls after announcing public offering plans - Investing.com

Investing.com • Sep 18

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Jasper Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Jasper Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Jasper Therapeutics, Inc. have?

Jasper Therapeutics, Inc. has approximately 27 employees.

What industry is Jasper Therapeutics, Inc. in?

Jasper Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Jasper Therapeutics, Inc. a publicly traded company?

Yes, Jasper Therapeutics, Inc. is publicly traded under the ticker symbol JSPRW on the NCM.

Where is Jasper Therapeutics, Inc. headquartered?

Jasper Therapeutics, Inc. is headquartered in Redwood City, CA, United States at 2200 Bridge Pkwy, Redwood City, CA 94065, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.